A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis. 1992

M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
Department of Medicine, Flinders University of SA, Adelaide.

The elderly (age > 65 years) are more vulnerable to side-effects induced by non-steroidal anti-inflammatory drugs (NSAIDs). We therefore performed a double-blind comparative study of ketoprofen SR and sulindac in patients with active rheumatoid arthritis, 65 years of age or older. Sulindac was chosen because of its possible renal sparing effects, and ketoprofen SR because of its short half life and sustained release delivery system. Eighty patients were entered. More patients withdrew from the study due to side-effects in the sulindac group; both treatment groups had a high incidence of side-effects during this study and during previous exposure to other NSAIDs, demonstrating that the elderly are susceptible to side-effects from NSAIDs.

UI MeSH Term Description Entries
D007660 Ketoprofen An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis. Benzoylhydratropic Acid,19,583 RP,2-(3-Benzoylphenyl)propionic Acid,Alrheumat,Alrheumum,Orudis,Profenid,RP-19583,RP 19583,RP, 19,583,RP19583
D008297 Male Males
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013467 Sulindac A sulfinylindene derivative prodrug whose sulfinyl moiety is converted in vivo to an active NSAID analgesic. Specifically, the prodrug is converted by liver enzymes to a sulfide which is excreted in the bile and then reabsorbed from the intestine. This helps to maintain constant blood levels with reduced gastrointestinal side effects. Aclin,Apo-Sulin,Arthrobid,Arthrocine,Chibret,Clinoril,Copal,Kenalin,Klinoril,MK-231,Novo-Sundac,Nu-Sulindac,Sulindal,Apo Sulin,MK 231,MK231,Novo Sundac,Nu Sulindac
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1977, Current medical research and opinion,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1978, Rheumatology and rehabilitation,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
April 1979, The New Zealand medical journal,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1982, European journal of rheumatology and inflammation,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1983, Current medical research and opinion,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
February 1985, Seminars in arthritis and rheumatism,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1978, Verhandlungen der Deutschen Gesellschaft fur Rheumatologie,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1980, Reumatizam,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1995, Rheumatology international,
M J Ahern, and M Wetherall, and A Leslie, and R H James, and P J Roberts-Thomson, and G C Rennie
January 1976, Rheumatology and rehabilitation,
Copied contents to your clipboard!